The Latest

Current News | News Archives |

• Welcome to the Wild Wireless Frontier 1/30/2015

  Egret Technologies’ CEO, Dr. Liam Pender, is an invited guest speaker at the upcoming Medical Device & Manufacturers (MD&M West) Conference on February 10-12, 2015 in Anaheim, California.
  Read More »

• U.S. FDA Approves Dexcom G4 Platinum Continuous Glucose Monitoring System with Share 1/26/2015

  Egret Technologies congratulates its client Dexcom, a leader in continuous glucose monitoring, on the announcement today that the U.S. Food and Drug Administration has approved its Dexcom G4® PLATINUM Continuous Glucose Monitoring System with Share.
  Read More »

• mHealth Interoperability Insights at MD&M East Conference 6/10/2014

  Egret Technologies’ CEO, Dr. Liam Pender, was an invited guest moderator at the Medical Device & Manufacturers (MD&M) East Conference on June 9-12, 2014 at the Javits Convention Center in New York City.
  Read More »

• NBC profiles the Bionic Pancreas Performance 6/10/2014

  NBC News published a story today that shared the success of the Bionic Pancreas out-patient trials that have been recently run. The results surpassed anything the researchers had hoped for. The clinical data was recently pubiished in the New England Journal of Medicine and the lead investigators will present at the American Diabetes Association Scientific Sessions next weekend. The technology was developed in a multi-body partnership including Egret Technologies.
  Read More »

• mHealth Insights at MD&M Executive Summit 2/11/2014

  Egret Technologies’ CEO, Dr. Liam Pender, was an invited guest panelist at the inaugural Medical Device & Manufacturers (MD&M) Executive Summit on February 10-11, 2014 in Anaheim, California.
  Read More »

• USA Today covers the Bionic Pancreas 2/11/2014

  Today USA Today published a story sharing the story of one of the 30 adults who participated in Boston University clinical trials of the Bionic Pancreas. This mobile-device platform, the brainchild of Professor Ed Damiano, consists of closed-loop algorithms running on the iPhone, integrating the Dexcom G4 Platinum continuous glucose monitoring (CGM) system with Tandem Diabetes t:slim infusion pumps. The technology was developed in a multi-body partnership including Egret Technologies.
  Read More »

• mHealth devices must collect data automatically 1/27/2014

  Egret Technologies’ CEO, Dr. Liam Pender was interviewed by Medical Device + Diagnostic Industry magazine (MD+DI) to share his experience on what makes commercially successful mHealth products. Among the requirements that Dr. Pender alluded to was the need for mHealth devices to collect data automatically. He shared a number of examples of Egret Technologies' work in wireless medical device design.
  Read More »

• Bluetooth LE enabled Medical Device submitted to the U.S. FDA 8/16/2013

  Egret Technologies' client today filed a Bluetooth LE-enabled medical device submission to the U.S. FDA. The device is based on a Nordic Semiconductor Ultra Lower Power (ULP) radio transceiver implementing the Bluetooth 4.0 protocol. The device has a complimentary iPhone application and is for patient self-monitoring of a chronic disease.
  Read More »

• Bionic Pancreas Summer Camp 2013 7/19/2013

  A summer camp of children with type 1 diabetes, running a clinical study assessing the efficacy of the bionic pancreas completed today. This study tested the hypothesis that a wearable automated bionic pancreas system that automatically delivers both insulin and glucagon could improve glycemic control vs. usual care for young people with type 1 diabetes 12-20 in a diabetes camp environment.
  Read More »

• FDA Workshop on Innovation Towards an Artificial Pancreas 4/10/2013

  Egret Technologies’ personnel were guests at the FDA workshop in collaboration with the National Institutes of Health (NIH) and the Juvenile Diabetes Research Foundation (JDRF). "Workshop on Innovation Towards an Artificial Pancreas” focusing on newly evolving technologies that will advance development of an artificial pancreas.
  Read More »